Conversely, overexpression of wild‐type PRMT1 (but not a methyltransferase‐dead mutant) via recombinant adeno‐associated virus reinstates PGC‐1α levels, enhances fatty acid oxidation, and mitigates NAFLD [17]. Here, PRMT1 is linked to metabolic dysfunction-associated steatotic liver disease.